» Alzinova reaches milestone in Alzheimer's study
» Lipigon's CEO on development and issue
» Stayble presents further positive interim data
» Neola Medical receives grant from Vinnova
» Issuance to take Lipigon through phase II
Read BioStock's newsletter for v.15 here.
Watch the latest episode of The IPO round in the banner below!
Morning news
Annexin Pharmaceuticals reports encouraging initial results in the imaging study of retinal vein occlusion. Read more.
Alzinova receives regulatory approval for extension part of phase Ib study. Read more.
BibbInstruments informs about the status of the CE marking process according to the MDR. Read more.
Alligator Bioscience announces poster presentation on ATOR-4066 at the AACR 2023 annual meeting. Read more.
Neola Medical will present study results at Pediatric Academic Societies Meeting at the end of April. Read more.
Idogen is investigating reverse acquisitions to avoid the risk of liquidation. Read more.
New data confirms that Senzimes TetraGraph supports doctors in clinical decisions and ensures patient safety. Read more.
Inhalation Sciences complete all preparations for FDA BAA-contract research projects. Read more.
ArcticZymes Technologies launches ArcticZymes Proteinase HQ. Read more.
Bioservo signs a distribution agreement with Anatomical Concepts for sale of Carbonhand in Great Britain. Read more.
Medicover socially sustainable commercial papers are listed on Nasdaq Stockholm. Read more.
BergenBio presenting data at AACR 2023. Read more.
Real Heart announces that Joseph Bornoff simulations of Realheart has been published in Scientific Reports. Read more.
Kiwok is participating in an application for European research funding. Read more.
NextCell TUBE, Dr. Lindsay Davies, is an invited speaker at European Wound Management Association in Milan. Read more.
Attana begins the second year of a five-year service and support contract from a health institute in the US. Read more.
By having is recruiting Commercial Lead. Read moreThe company also announces the last day for trading in BTU and the first day for trading in warrants of series TO 2. Read more.
Nexstim provides information about share subscriptions and share ownership programs. Read more.
Faron Pharmaceuticals participating with poster presentations at AACR 2023. Read more.
Calmark clarifies and comments on the auditor's statement in the audit report. Read more.
Annual Reports:
Arcede Pharma Calmark Elicera Therapeutics Surgical Science Respirator
Summons:
Asarina Pharma RaySearch Laboratories
News since Monday lunch
Pharmacologist has announced a new strategic direction. Read more.
The board, management team and co-founders have subscribed for units in Lipigons ongoing rights issue. Read more.
Cantargia has presented new positive clinical data at AACR 2023 regarding nadulonimab in pancreatic cancer. Read more.
Cline Scientific has decided on a new share issue of approximately SEK 6,3 million. Read more.
ALK-Abelló has published preliminary figures for Q1 and confirms its revenue and profit outlook for the full year. Read more.
Attana has announced that the company has terminated its mentoring agreement. Read more.
SensoDetect is visiting Saudi Arabia as part of the company's commercialization plan in the region. Read more.
CellaVision has published preliminary results for Q1 2023. Read more.
Details in Raytelligences Rights issue regarding registration, cessation of trading in BTU and change in share capital has been announced. Read more.
Demant has announced a capital reduction. Read more.
This morning's price development
Winner: Hemcheck 35,9%, Prostatype Genomics 32,3%, Alteco 18,8%, Abera Bioscience 13,9%, Dicot 10,5%
Förlorare: Calmark -17,5%, Redwood Pharma -12,8%, CellaVision -10,5%, Idogen -10,5, Lipidor -9,5%
Index: OMXS30 2253 0,16%, Healthcare 0,24%